An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

NCT01211652 ·Status: COMPLETED

The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users

NCT01814943 ·Status: COMPLETED

Aspirin Responsiveness in Women at Risk for Cardiac Events

NCT00818337 ·Status: COMPLETED ·Phase: PHASE4

Aspirin Responsiveness in Women With Coronary Artery Disease

NCT01406990 ·Status: COMPLETED

Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)

NCT00981032 ·Status: COMPLETED ·Phase: NA

The Clinical Benefit and Risk of Oral Aspirin for Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia

NCT02846259 ·Status: UNKNOWN

Aspirin to Target Arterial Events in Chronic Kidney Disease

NCT03796156 ·Status: TERMINATED ·Phase: PHASE3

Risk of Uncomplicated Peptic Ulcer in the General Population

NCT01888588 ·Status: COMPLETED

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

NCT00501059 ·Status: COMPLETED ·Phase: PHASE3

Duration of Platelet Inhibition by Aspirin

NCT00671021 ·Status: COMPLETED

Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE

NCT05907902 ·Status: UNKNOWN ·Phase: PHASE3

Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

NCT01888575 ·Status: COMPLETED

Observational Aspirin Use and CVD in the Physicians' Health Study

NCT00005493 ·Status: COMPLETED

Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome

NCT01952392 ·Status: COMPLETED

Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.

NCT07125651 ·Status: NOT_YET_RECRUITING

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

NCT02550717 ·Status: COMPLETED

EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK

NCT03743883 ·Status: COMPLETED

First Approach for Aspirin Misuse Objective Screening

NCT02997436 ·Status: COMPLETED ·Phase: NA

Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease

NCT03757156 ·Status: UNKNOWN ·Phase: NA

Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population

NCT01615315 ·Status: COMPLETED

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

NCT04097912 ·Status: COMPLETED

Appropriateness of Aspirin Use in Medical Outpatients

NCT03387384 ·Status: UNKNOWN

A Healthy Female and Male Volunteers Aspirin Study

NCT01448031 ·Status: COMPLETED ·Phase: PHASE1

Timed Aspirin Chronobiome Study

NCT03590821 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Prospective Real-world Registry Describing Treatment Regimens

NCT03942913 ·Status: UNKNOWN